biopharma

AstraZeneca PLC (NYSE: AZN) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Pascal Soriot -- Executive Director and Chief Executive…

Nektar Therapeutics (NKTR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Jennifer Ruddock -- Senior Vice President, Strategy and Corporate…

Affimed N.V. (AFMD) Q1 2020 earnings call dated Jun. 23, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief…

Veru Inc. (VERU) Q2 2020 earnings call dated May 13, 2020 Corporate Participants: Sam Fisch -- Director of Investor Relations Mitchell Steiner -- Chairman,…

Veru Inc. (NASDAQ: VERU) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market…

Bristol-Myers Squibb Co (BMY) Q1 2020 earnings call dated May. 07, 2020 Corporate Participants: Timothy Power -- Vice President, Investor Relations Giovanni…

Novartis International AG (NVS) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations…

Celgene Corporation (NASDAQ: CELG) reported a 56% jump in earnings for the third quarter of 2019 helped by higher revenue…

Sarepta Therapeutics (NASDAQ: SRPT) reported a 29% rise in second quarter revenue, aided by the continuing increase in demand for…

MediWound Ltd. (NASDAQ: MDWD) stock plunged to a record low of $3.52 on Tuesday. The future of the biopharmaceutical company…

CymaBay Therapeutics (NASDAQ: CBAY) stock fell to a two-year low of $4.82 on Tuesday after disappointing nonalcoholic steatohepatitis (NASH) trial…

Biopharmaceutical company CorMedix (CRMD) reported its first quarter 2019 results after the bell today. CorMedix recorded a net loss of…

MannKind Corporation (NASDAQ: MNKD) reported a narrower loss in the first quarter of 2019 helped by higher total revenues. The…

Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) rose 13% on February 25 when the US patent office extended the patent…

Biopharma firm CorMedix (NYSE American: CRMD) has seen its shares skyrocket more than 500% in the last 12 months as…

As GW Pharmaceuticals (GWPH) moved its fiscal year beginning to January 1, 2019, the company reported financial results for the quarter…

Immunomedics (IMMU) plunged about 10% in the extended trading hours after the company announced about CEO Michael Pehl's exit from…

General Electric’s (GE) stock jumped around 15% in premarket hours on Monday after the company announced the sale of its…

AbbVie Inc. (ABBV) slipped to a loss in the fourth quarter from a profit last year, due to the inclusion…

Clinical stage biopharmaceutical company Axsome Therapeutics (AXSM) announces positive outcome for ADVANCE-1 trial associated with the treatment of Alzheimer's disease. Shares of…

Flexion Therapeutics (Nasdaq: FLXN) reported its preliminary fourth quarter earnings results after the bell today. The biopharmaceutical company's Q4 revenue is expected…